Sign Up to like & get
recommendations!
0
Published in 2023 at "Hematological oncology"
DOI: 10.1002/hon.3172
Abstract: Zanubrutinib has been approved for the treatment of patients with different lymphoproliferative disorders, and now represents a major breakthrough in the treatment of patients resistant or relapsing after the recommended therapies. Because few systematic studies…
read more here.
Keywords:
clinical needs;
use zanubrutinib;
zanubrutinib;
unmet clinical ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "CNS Spectrums"
DOI: 10.1017/s1092852923002146
Abstract: Abstract Introduction Recent research has highlighted the increasing ubiquity of smartphone ownership as well as the feasibility of digital interventions within schizophrenia. Digital therapeutics, a subset of digital interventions, have established standards for efficacy and…
read more here.
Keywords:
assessing unmet;
digital therapeutic;
unmet clinical;
opportunity ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Virulence"
DOI: 10.1080/21505594.2016.1276692
Abstract: The global impact of fungal infections on human health has recently been highlighted by several important publications, and advocacy groups. Although several factors undoubtedly contribute to the estimated 1.5 million deaths due to fungal disease…
read more here.
Keywords:
unmet clinical;
novel antifungal;
treatment;
antifungal drugs ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Artificial organs"
DOI: 10.1111/aor.13973
Abstract: Neonates, infants, and children have unique physiology and body surface areas that dramatically change during growth and development, and the substantial diversity of complicated pediatric illnesses and rare childhood diseases are distinct from the adult…
read more here.
Keywords:
unmet clinical;
engineering;
pediatric engineering;
innovation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14194941
Abstract: Simple Summary Several novel therapies are being developed to improve the management of patients with myelodysplastic syndromes. They include drugs aimed at improving hematopoiesis and differentiation of myeloid precursors, hypomethylating agents, several compounds that target…
read more here.
Keywords:
therapies unmet;
clinical needs;
novel therapies;
myelodysplastic syndromes ... See more keywords